DE60328916D1 - Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger - Google Patents

Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger

Info

Publication number
DE60328916D1
DE60328916D1 DE60328916T DE60328916T DE60328916D1 DE 60328916 D1 DE60328916 D1 DE 60328916D1 DE 60328916 T DE60328916 T DE 60328916T DE 60328916 T DE60328916 T DE 60328916T DE 60328916 D1 DE60328916 D1 DE 60328916D1
Authority
DE
Germany
Prior art keywords
bacillus subtilis
use against
against animal
human diseases
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60328916T
Other languages
German (de)
English (en)
Inventor
Huay Lin Angeline Seah
Alex Yeow-Lim Teo
Hai Meng Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Application granted granted Critical
Publication of DE60328916D1 publication Critical patent/DE60328916D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60328916T 2002-11-27 2003-11-12 Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger Expired - Lifetime DE60328916D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/306,365 US7247299B2 (en) 2002-11-27 2002-11-27 Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
PCT/US2003/036094 WO2004050832A2 (en) 2002-11-27 2003-11-12 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens

Publications (1)

Publication Number Publication Date
DE60328916D1 true DE60328916D1 (de) 2009-10-01

Family

ID=32325671

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60328916T Expired - Lifetime DE60328916D1 (de) 2002-11-27 2003-11-12 Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger

Country Status (10)

Country Link
US (1) US7247299B2 (https=)
EP (1) EP1576120B1 (https=)
JP (1) JP4989851B2 (https=)
AT (1) ATE440132T1 (https=)
AU (1) AU2003291514B2 (https=)
CA (1) CA2503130C (https=)
DE (1) DE60328916D1 (https=)
ES (1) ES2331993T3 (https=)
NZ (1) NZ568391A (https=)
WO (1) WO2004050832A2 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US20080193577A1 (en) * 2005-11-04 2008-08-14 Ahc Co., Ltd. Antibacterial Substance Dm0507 and Utilization of the Same
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
US8021654B2 (en) * 2008-03-14 2011-09-20 Danisco A/S Methods of treating pigs with Bacillus strains
CA2721180C (en) 2008-04-17 2016-10-11 Danisco A/S Bacillus strains useful for animal odor control
US8540981B1 (en) 2008-07-07 2013-09-24 Dupont Nutrition Biosciences Aps Bacillus strains useful against calf pathogens and scours
AU2009293213C1 (en) * 2008-09-17 2015-04-30 Bayer Cropscience Lp Method for using a Bacillus subtilis strain to enhance animal health
JP5620392B2 (ja) * 2008-11-03 2014-11-05 タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
US20120301450A1 (en) 2010-02-10 2012-11-29 Hirokuni Miyamoto Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
EP2547348B1 (en) * 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
WO2012009712A2 (en) 2010-07-16 2012-01-19 The Board Of Trustees Of The University Of Arkansas Methods and compositions including spore-forming bacteria for increasing the health of animals
MX339951B (es) * 2010-09-15 2016-06-20 Investig De Tecnologia Avanzada S A De C V Bacillus subtilis aislado de maiz.
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
US9205116B2 (en) 2011-04-29 2015-12-08 Auburn University Bacillus bacteria for use in treating and preventing infection in aquatic animals
US8557234B1 (en) 2011-05-18 2013-10-15 Dupont Nutrition Biosciences Aps Methods of controlling pit foam
DK2748300T3 (en) 2011-08-24 2019-01-14 Dupont Nutrition Biosci Aps ENZYM-PRODUCING BACILLUS STUMS
MX2014009103A (es) 2012-01-27 2015-11-18 Gfs Corp Aus Pty Ltd Métodos para producir biosurfactantes.
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
RU2534356C2 (ru) * 2012-10-04 2014-11-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Россельхозакадемии (ГНУ ИЭВСиДВ Россельхозакадемии) Способ контроля качества дезинфекции птицеводческих помещений
WO2014151837A1 (en) * 2013-03-15 2014-09-25 Bayer Cropscience Lp A bacillus subtilis strain for use in maintaining or improving the paw health of poultry
EP3203858A1 (en) * 2014-10-08 2017-08-16 Novozymes A/S Bacillus strains with fast germination and antimicrobial activity against clostridium perfringens
US11331351B2 (en) 2015-01-23 2022-05-17 Novozymes A/S Bacillus strains improving health and performance of production animals
EP3261653B1 (en) 2015-01-23 2019-10-09 Novozymes A/S Bacillus subtilis subspecies
AU2016209132B2 (en) 2015-01-23 2021-07-01 Novozymes A/S Bacillus strains improving health and performance of production animals
US10201574B1 (en) 2015-09-16 2019-02-12 Church & Dwight Co., Inc. Methods of microbial treatment of poultry
US11298383B2 (en) 2016-05-20 2022-04-12 Church & Dwight Co., Inc. Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use
EP3464648A1 (en) 2016-05-25 2019-04-10 Church & Dwight Co., Inc. Bacillus compositions and methods of use with ruminants
JP2019522468A (ja) 2016-05-31 2019-08-15 エボニック デグサ ゲーエムベーハーＥｖｏｎｉｋ Ｄｅｇｕｓｓａ ＧｍｂＨ プロバイオティック活性を示すバチルス・リケニフォルミス（Ｂａｃｉｌｌｕｓ ｌｉｃｈｅｎｉｆｏｒｍｉｓ）菌株
US11173184B2 (en) 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
WO2019002476A1 (en) 2017-06-30 2019-01-03 Evonik Degussa Gmbh BACILLUS PUMILUS STRAIN HAVING PROBIOTIC ACTIVITY
JP7104078B2 (ja) 2017-06-30 2022-07-20 エボニック オペレーションズ ゲーエムベーハー プロバイオティクス活性がある枯草菌株
US11622569B2 (en) 2017-07-24 2023-04-11 Church & Dwight Co., Inc. Bacillus microbial terroir for pathogen control in swine
WO2019038153A1 (en) 2017-08-24 2019-02-28 Evonik Degussa Gmbh DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY
EP3447122A1 (en) 2017-08-24 2019-02-27 Evonik Degussa GmbH Bacillus subtilis strain with probiotic activity
CN108865953B (zh) * 2018-07-25 2021-07-13 中国海洋大学 一株广谱抑制水产病原性弧菌的芽孢杆菌及其复合菌制剂
BR112021013484A2 (pt) 2019-01-10 2021-09-14 Evonik Operations Gmbh Caldo de fermentação seco de micro-organismos, composição e métodos
MX2021009443A (es) 2019-02-11 2021-09-10 Evonik Operations Gmbh Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas.
CN110894132A (zh) * 2019-12-17 2020-03-20 海天水务集团股份公司 一种基于fcr的污水处理方法
MX2022008631A (es) 2020-01-14 2022-08-08 Evonik Operations Gmbh Cepas de bacillus con capacidad de degradar compuestos de nitrogeno inorganico.
AU2021207984A1 (en) * 2020-01-17 2022-08-25 AgBiome, Inc. Compositions and methods for controlling undesirable microbes and improving animal health
US20210283199A1 (en) * 2020-03-13 2021-09-16 Kemin Industries, Inc. Method for controlling clostridium infection in animals
MX2023006676A (es) 2020-12-09 2023-07-04 Purina Animal Nutrition Llc Composiciones alimenticias y metodos para inhibir dermatitis ulcerosa focal.
EP4130258A1 (en) 2021-08-02 2023-02-08 Evonik Operations GmbH Microorganisms displaying viral decoy receptors
EP4166002A1 (en) 2021-10-12 2023-04-19 Evonik Operations GmbH Microbial preparations containing specific cryoprotectants
EP4230722A1 (en) 2022-02-17 2023-08-23 Evonik Operations GmbH Bacillota strains with improved outgrowth
EP4230721A1 (en) 2022-02-17 2023-08-23 Evonik Operations GmbH Microorganisms with reduced competence
WO2023180282A1 (en) 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds
WO2023220279A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Compositions and methods for the treatment and prevention of campylobacter infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545991A (en) 1983-06-13 1985-10-08 Merck & Co., Inc. Difficidin and derivative antibacterials
DE3778225D1 (de) * 1986-06-30 1992-05-21 American Cyanamid Co Antibiotikum ll-e19020 alpha und beta.
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US5352586A (en) * 1987-05-01 1994-10-04 Biogaia Ab Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
JPH0818996B2 (ja) * 1987-10-31 1996-02-28 カルピス食品工業株式会社 抗クロストリジウム生菌剤
EP0463393B1 (en) * 1990-06-22 1995-11-15 ENIRICERCHE S.p.A. A mutant of bacillus subtiles and a method of producing surfactin with the use of the mutant
DE69225454T2 (de) * 1991-07-01 1998-10-01 Ahc Inc Bacillus Bakterium und dessen Verwendung
ZA926834B (en) * 1991-09-09 1993-03-15 American Cyanamid Co Antibiotic LL-E19020 Gamma.
ATE160570T1 (de) * 1991-09-09 1997-12-15 Hoffmann La Roche Antibiotikum ll-e19020 gamma
JP2528055B2 (ja) * 1991-10-04 1996-08-28 カルピス食品工業株式会社 鳥類飼料添加用腸内サルモネラ属細菌減少剤及びその使用法
WO1999028441A1 (en) 1997-12-01 1999-06-10 Eisai Co., Ltd. Novel bacillus subtilis with antibacterial effects
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)

Also Published As

Publication number Publication date
JP4989851B2 (ja) 2012-08-01
AU2003291514B2 (en) 2008-10-09
JP2006514019A (ja) 2006-04-27
CA2503130C (en) 2012-03-13
CA2503130A1 (en) 2004-06-17
US20040101525A1 (en) 2004-05-27
WO2004050832A3 (en) 2005-09-15
EP1576120A4 (en) 2006-06-07
ATE440132T1 (de) 2009-09-15
EP1576120A2 (en) 2005-09-21
AU2003291514A1 (en) 2004-06-23
WO2004050832A2 (en) 2004-06-17
US7247299B2 (en) 2007-07-24
EP1576120B1 (en) 2009-08-19
NZ568391A (en) 2009-04-30
ES2331993T3 (es) 2010-01-22

Similar Documents

Publication Publication Date Title
DE60328916D1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
DE60129823D1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
Liu et al. Frequency of biocide-resistant genes and susceptibility to chlorhexidine in high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA)
Bin-Asif et al. The genus Enterococcus and its associated virulent factors
WO2009088549A3 (en) Methods of inhibiting bacterial virulence and compounds relating thereto
MX336242B (es) Uso de los compuestos a base de lantibioticos del tipo b que tienen actividad antimicrobiana.
WO2004103208A3 (en) Manufacture and use of implantable reticulated elastomeric matrices
MX2009007345A (es) Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
Arciola et al. Presence of fibrinogen-binding adhesin gene in Staphylococcus epidermidis isolates from central venous catheters-associated and orthopaedic implant-associated infections
WO2009022185A3 (en) 6, 6-fused heterocycles, their pharmaceutical compositions and methos of use
DE50306587D1 (de) Antibakterielle amid-makrozyklen
TW200738249A (en) Harmful bacterium control agent containing bacillus thuringiensis
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
Sood et al. Multidrug resistant Bacillus cereus in fresh vegetables: A serious burden to public health
DE60318558D1 (de) Verwendung von lactobacillus farciminis zur prophylaxe oder behandlung von verdauungserkrankungen
WO2007092582A3 (en) Neutralization of bacterial spores
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
UA85187C2 (en) 2-aminobenzoyl derivatives
Yan et al. Complete genome sequence of Bacillus amyloliquefaciens B15 isolated from grape skin, a strain of strong inhibitory activity against fungi
Handayani et al. Staphylococcal enterotoxin a gene–carrying Staphylococcus aureus isolated from foods and its control by crude alkaloid from papaya leaves
RU2003110469A (ru) Штамм бактерий bacillus subtilis ч-13
WO2002086154A3 (en) Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
ATE473295T1 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
Gobius Transfer of antimicrobial resistant bacteria in food

Legal Events

Date Code Title Description
8364 No opposition during term of opposition